DK0675724T3 - Anvendelse af didesoxynucleosidanaloger til behandling af virale infektioner - Google Patents

Anvendelse af didesoxynucleosidanaloger til behandling af virale infektioner

Info

Publication number
DK0675724T3
DK0675724T3 DK94904110.7T DK94904110T DK0675724T3 DK 0675724 T3 DK0675724 T3 DK 0675724T3 DK 94904110 T DK94904110 T DK 94904110T DK 0675724 T3 DK0675724 T3 DK 0675724T3
Authority
DK
Denmark
Prior art keywords
didesoxynucleoside
analogues
viral infections
treat viral
treat
Prior art date
Application number
DK94904110.7T
Other languages
English (en)
Inventor
Tarek Mansour
Alan H L Tse
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Application granted granted Critical
Publication of DK0675724T3 publication Critical patent/DK0675724T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94904110.7T 1992-12-24 1993-12-22 Anvendelse af didesoxynucleosidanaloger til behandling af virale infektioner DK0675724T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226927A GB9226927D0 (en) 1992-12-24 1992-12-24 Dideoxy nucleoside analogues

Publications (1)

Publication Number Publication Date
DK0675724T3 true DK0675724T3 (da) 1998-03-09

Family

ID=10727197

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94904110.7T DK0675724T3 (da) 1992-12-24 1993-12-22 Anvendelse af didesoxynucleosidanaloger til behandling af virale infektioner

Country Status (21)

Country Link
US (1) US6156737A (da)
EP (2) EP0765665A1 (da)
JP (2) JP2818299B2 (da)
KR (1) KR100331714B1 (da)
AP (1) AP450A (da)
AT (1) ATE157877T1 (da)
AU (1) AU681370B2 (da)
CA (1) CA2143204C (da)
DE (1) DE69313872T2 (da)
DK (1) DK0675724T3 (da)
ES (1) ES2108969T3 (da)
GB (1) GB9226927D0 (da)
GR (1) GR3024699T3 (da)
HK (1) HK1002426A1 (da)
IL (1) IL108063A (da)
MY (1) MY127808A (da)
NZ (1) NZ259487A (da)
RU (1) RU2160108C2 (da)
SG (1) SG48956A1 (da)
WO (1) WO1994014456A1 (da)
ZA (1) ZA939677B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346627B1 (en) * 1990-02-01 2002-02-12 Emory University Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
CA2637774C (en) * 1993-09-10 2011-07-19 Emory University Nucleosides with anti-hepatitis b virus activity
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) * 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
WO1996040164A1 (en) 1995-06-07 1996-12-19 Emory University Nucleosides with anti-hepatitis b virus activity
US6100301A (en) * 1996-02-28 2000-08-08 Pfizer Inc Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
ZA984796B (en) * 1997-06-10 1998-12-29 Chong Kun Dang Corp Novel optically active nucleoside derivative its manufacturing method and anti-HBV composition containing the derivative thereof
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
DK224286A (da) * 1985-05-15 1986-11-16 Wellcome Found 2',3'-dideoxy-nucleosider
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
IL85778A0 (en) * 1987-03-20 1988-09-30 Bristol Myers Co Production of 2',3'-dideoxynucleosides and certain such novel compounds
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
AU5659990A (en) * 1989-05-15 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of treatment of hepatitis
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5179104A (en) * 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
NZ241625A (en) * 1991-02-22 1996-03-26 Univ Emory 1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers
EP1142891B1 (en) * 1991-03-06 2007-05-02 Emory University Salts and amides of (-)cis 5-Fluoro-2'-deoxy-3'-thiacytidine useful for the treatment of hepatitis B
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
JPH09222548A (ja) * 1996-02-19 1997-08-26 Asahi Optical Co Ltd レンズ駆動機構

Also Published As

Publication number Publication date
CA2143204A1 (en) 1994-07-07
MY127808A (en) 2006-12-29
ES2108969T3 (es) 1998-01-01
RU2160108C2 (ru) 2000-12-10
CA2143204C (en) 1997-06-03
IL108063A (en) 1999-10-28
IL108063A0 (en) 1994-04-12
HK1002426A1 (en) 1998-08-21
KR100331714B1 (ko) 2002-11-01
SG48956A1 (en) 1998-05-18
WO1994014456A1 (en) 1994-07-07
ZA939677B (en) 1994-08-26
DE69313872D1 (de) 1997-10-16
GB9226927D0 (en) 1993-02-17
AP450A (en) 1996-01-19
JP2818299B2 (ja) 1998-10-30
NZ259487A (en) 1997-06-24
US6156737A (en) 2000-12-05
DE69313872T2 (de) 1998-01-08
GR3024699T3 (en) 1997-12-31
ATE157877T1 (de) 1997-09-15
AU5830194A (en) 1994-07-19
AU681370B2 (en) 1997-08-28
EP0675724B1 (en) 1997-09-10
EP0765665A1 (en) 1997-04-02
EP0675724A1 (en) 1995-10-11
JPH07509730A (ja) 1995-10-26
AP9300603A0 (en) 1994-01-31
JPH10139668A (ja) 1998-05-26

Similar Documents

Publication Publication Date Title
DK0675724T3 (da) Anvendelse af didesoxynucleosidanaloger til behandling af virale infektioner
DK0672057T3 (da) Analoger af PTH
DK156688A (da) Praeparat til behandling af virusinfektioner
DK405286D0 (da) Anvendelse af dobbeltstrenget rna til behandling af aids
DK208188A (da) Anvendelse af 17-ketosteroider
KR950702629A (ko) 생물학적 제제를 연속적으로 적용시키는 붕대(bandage for continuous application of biologicals)
DK112387D0 (da) Rensning af alfa-1-antiprotease
BR9106901A (pt) Peca estrutural de multiplos componentes
MX163744B (es) Estructuras protectoras de defensa
DK186087A (da) Anvendelse af pseudomonsyre til behandling af fungale infektioner
DK160220C (da) Panservaeg af saakaldt aktivt panser
DE69306607D1 (de) Reinigung von niedrigem Alkylenoxyd
DE69507215D1 (de) Reinigung von Bisphenol-A
DK363887D0 (da) Anvendelse af bromcruptin
DE69405329D1 (de) Reinigung von 2-Methylglutaro- oder Adiponitril
NO940810D0 (no) Behandling av virusinfeksjoner
DK0676951T3 (da) Anvendelse af vitamin-D-glycosider til behandling eller forebyggelse af osteoporose
DE69301599D1 (de) Reinigung von Propylenoxid
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK298187A (da) Applikator til behandling af laeber
NO940190L (no) Anvendelse av alpha-ketoglutarat
ITBS910107V0 (it) Camminatoio per i primi passi di bambini
DK0689577T3 (da) Anvendelse af ferroncen
DE69030414D1 (de) Reinigung von Albumin
DK82592D0 (da) Fremstilling af proteiner